Pharsight

KRKA TOVARNA ZDRAVIL DD PATENTS FACING OPPOSITIONS

Top patents of KRKA TOVARNA ZDRAVIL DD facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2588090B2 22 Nov, 2023 Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts NA 3
EP3309158B1 16 Mar, 2022 Crystalline Form K Of Rivaroxaban And Process For Its Preparation Dec, 2033 1
EP2585051B2 08 Apr, 2020 Pharmaceutical Oral Dosage Forms Comprising Lercanidipine And Enalapril And Their Pharmaceutically Acceptable Salts NA 1